Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease

Affiliations

• ¹ Department of Gastroenterology, University Medical Center Ljubljana, Ljubljana, Slovenia.
• ² Alimentiv, #200, 100 Dundas Street, London, N6A 5B6, ON, Canada.
• ³ , Hullenbergweg 278-308, 1101 BV, Amsterdam, The Netherlands.
• ⁴ Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, 6D61 Teaching Research Wellness Building, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada.
• ⁵ Department of Medicine, University of California San Diego, 9500 Gilman Drive #0956, La Jolla, CA, 92093, USA.
• ⁶ Division of Gastroenterology, University of Western Ontario, 1151 Richmond Street, London, N6A 2K7, ON, Canada.
• ⁷ Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.
• ⁸ Alimentiv, #200, 100 Dundas Street, London, N6A 5B6, ON, Canada. brian.feagan@alimentiv.com.
• ⁹ Division of Gastroenterology, University of Western Ontario, 1151 Richmond Street, London, N6A 2K7, ON, Canada. brian.feagan@alimentiv.com.
• ¹⁰ Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada. brian.feagan@alimentiv.com.
• ¹¹ Department of Medicine, University of Western Ontario, London, ON, Canada. brian.feagan@alimentiv.com.